Related Experiment Video
Updated: Feb 5, 2026

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
Published on: March 12, 2018
PLK1 targets CtIP to promote microhomology-mediated end joining
Hailong Wang1, Zhiyu Qiu1, Bo Liu1
1Beijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing 100048, China.
Abstract:
Proper DNA double-strand break (DSB) repair is essential for maintaining genome integrity. Microhomology-mediated end joining (MMEJ) is an error-prone repair mechanism, which introduces mutations at break sites and contributes to chromosomal translocations and telomere fusions, thus driving carcinogenesis. Mitotic kinases PLK1, CDK1 and Aurora A are important for supporting MMEJ and are often overexpressed in various tumors. However, the functional interplay between these kinases and MMEJ has not been explored. Here, we found that MMEJ is preferentially employed to fix DSBs in cells arrested in mitosis following nocodazole treatment. We further showed that the DSB repair factor CtIP is jointly phosphorylated by CDK1/Aurora A and PLK1. CDK1/Aurora A-mediated CtIP phosphorylation at serine 327 triggers CtIP binding to the PLK1 polo-box domain, which in turn facilitates PLK1 to phosphorylate CtIP mainly at serine 723. A PLK1 phosphor-mimic CtIP mutant fails to initiate extended end resection and is thus unable to mediate homologous recombination and the G2/M checkpoint but can mediate MMEJ. These data imply that PLK1 may target CtIP to promote error-prone MMEJ and inactivate the G2/M checkpoint. These findings have helped elucidate the oncogenic roles of these factors.
Insights
Mitotic kinases like PLK1, CDK1, and Aurora A promote microhomology-mediated end joining (MMEJ), an error-prone DNA repair pathway. This study reveals how these kinases target CtIP to favor MMEJ, potentially driving cancer progression.
Area of Science:
- Cellular biology
- Molecular oncology
- DNA repair mechanisms
Background:
- DNA double-strand breaks (DSBs) require precise repair for genome stability.
- Microhomology-mediated end joining (MMEJ) is an error-prone DSB repair pathway linked to carcinogenesis.
- Mitotic kinases (PLK1, CDK1, Aurora A) are implicated in MMEJ and often overexpressed in tumors.
Purpose of the Study:
- To investigate the functional interplay between mitotic kinases and the MMEJ pathway.
- To elucidate the molecular mechanisms by which PLK1, CDK1, and Aurora A influence DSB repair choices.
Main Methods:
- Nocodazole-induced mitotic arrest to study DSB repair.
- Phosphorylation site analysis of the DSB repair factor CtIP.
- Site-directed mutagenesis to create CtIP phosphorylation mimic mutants.
Main Results:
- MMEJ is the preferred DSB repair pathway in mitotic-arrested cells.
- CDK1/Aurora A and PLK1 cooperatively phosphorylate CtIP at distinct sites (Ser327 and Ser723).
- A CtIP phosphorylation mimic mutant impairs homologous recombination and G2/M checkpoint but promotes MMEJ.
Conclusions:
- PLK1 targets CtIP to promote error-prone MMEJ over homologous recombination.
- This mechanism may contribute to the oncogenic roles of these kinases by inactivating the G2/M checkpoint and promoting MMEJ.
- Findings illuminate novel therapeutic targets for cancer treatment.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Anaphase Promoting Complex
Receptor-mediated Endocytosis
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

